Advertisement
Advertisement

NKTX

NKTX logo

Nkarta, Inc. Common Stock

2.90
USD
Sponsored
0.00
+0.17%
Jun 25, 12:00 UTC -4
Open

Nkarta, Inc. Common Stock Profile

About

Nkarta Inc. is a biopharmaceutical company. It develops and commercializes cell therapies for cancer treatment. The company's product candidate includes NKX101 and NKX019, which are in clinical stage. Nkarta Inc. is based in South San Francisco, California.

Info & Links

CEO

Paul J. Hastings

Headquarters

1150 VETERANS BOULEVARD
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.nkartatx.com

Auditor

Ernst & Young LLP

Share holders

16

Employees

108

Nkarta, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

207.12M

Enterprise Value

179.77M

Enterprise Value/EBITDA(ttm)

-1.62

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.53

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-30.02%

Return on Invested Capital(ttm)

-30.07%

Return on Assets(ttm)

-23.78%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-110.84M

Net Income Available to Common(ttm)

-99.93M

Diluted EPS(ttm)

-1.40

Share Statistics

Beta (5Y Monthly)

0.66

52-Week Change

65.43%

S&P 500 52-Week Change

21.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

71.55M

Dividend Yield

0.00%

Float4

68.05M

% Held by Insiders

8.40%

% Held by Institutions

80.54%

Balance Sheet

Total Cash(mrq)

230.43M

Total Cash Per Share(mrq)

3.22

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

12.69%

Quick Ratio(mrq)

12.69%

Book Value Per Share(mrq)

4.39

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.20

Free Cash Flow(ytd)

-89.91M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement